AP
ADIAL PHARMACEUTICALS, INC.
SEC filingPharmaceuticals · Glen Allen, VA
Amount raised$4.3Msold at filing
Total offering$4.3M
Investors in the raise1count reported to the SEC
FiledDec 3, 2025first sale Nov 28, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
James W. Newman, Jr.Director
James K. AndersonDirector
Vinay J. ShahExecutive Officer
Robertson H. GillilandDirector
Tony W. GoodmanExecutive Officer, Director
Kevin W. Schuyler, CFADirector
Cary J. ClaiborneExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.